[go: up one dir, main page]

AR042900A1 - Productos n-aril-heteroaromaticos, composiciones que les contienen y su utilizacion - Google Patents

Productos n-aril-heteroaromaticos, composiciones que les contienen y su utilizacion

Info

Publication number
AR042900A1
AR042900A1 ARP040100138A ARP040100138A AR042900A1 AR 042900 A1 AR042900 A1 AR 042900A1 AR P040100138 A ARP040100138 A AR P040100138A AR P040100138 A ARP040100138 A AR P040100138A AR 042900 A1 AR042900 A1 AR 042900A1
Authority
AR
Argentina
Prior art keywords
aryl
heteroaryl
alkyl
group
substituted
Prior art date
Application number
ARP040100138A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of AR042900A1 publication Critical patent/AR042900A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Productos N-aril-heteroaromáticos, composiciones que les contienen, y su utilización como medicamento, en particular en oncología. Reivindicación 1: Producto que responde a la fórmula (1), en la cual: R1 y R2 se seleccionan independientemente del grupo constituido por arilo, heteroarilo, arilo sustituido y heteroarilo sustituido; R2 se puede igualmente elegir entre el grupo cicloalquilo C5-7; L se selecciona del grupo constituido por C(R7)(R8), C=O, C=S y C=N(R7); R3 se selecciona del grupo constituido por H, halógeno, CF3, alquilo, alquilo sustituido, alquileno, alquileno sustituido, alquinilo, alquinilo sustituido, cicloalquilo, cicloalquileno, heterociclilo, CO-R7, C[N-O(R8)](R7), COOH, CONH-arilo, CONH-heteroarilo, CONH-R7, CON(R7)(R8), CO-N(R7)-arilo, CO-N(R7)-heteroarilo, C(OR7)=NH, C[N(R7)(R8)]=NH, NH2, NH-arilo, NH-heteroarilo, NH(R7), N(R7)(R8), NH-CO-R7, N(R7)-CO-arilo, N(R7)-CO-heteroarilo, NH-SO2-R7, NH-SO2-arilo, NH-SO2-heteroarilo, NH-CH2-CO2R7, NH-CH2-arilo, NH-CH2-heteroarilo, N(R7)-N(R8)(R10), N-N=C(R7)(R8), CN, O-R7, S-R7, SO2-R7, SO2-R7, arilo, heteroarilo, cicloalquilo sustituido, arilo sustituido y heteroarilo sustituido; R4 se selecciona del grupo constituido por H, alquilo C1-3, ciclopropilo, alquileno C1-3, alquinilo C1-3, O-alquilo C1-3, S-alquilo C1-3, F, Cl y Br; R5 y R6 se seleccionan independientemente del grupo constituido por H, alquilo C1-3, oxo y halógeno; R7, R8 y R10 se seleccionan independientemente del grupo constituido por H, alquilo C1-3 y alquilo C1-3 sustituido; L-G-R1 se selecciona del grupo constituido por un resto de grupo de fórmula (2), con L y R1 son tales como se definen precedentemente, y R9 es igual a alquilo C1-3, bajo forma racémica, enriquecida con un enantiómero, enriquecida con un diastereoisómero, sus tautómeros, sus fármacos y sus sales farmacéuticamente aceptables, bajo reserva que el producto de fórmula (1) no sea uno de los compuestos de fórmula (3).
ARP040100138A 2003-01-28 2004-01-19 Productos n-aril-heteroaromaticos, composiciones que les contienen y su utilizacion AR042900A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0300894A FR2850379B1 (fr) 2003-01-28 2003-01-28 Produits n-aryl-heteroaromatiques, compositions les contenant et utilisation

Publications (1)

Publication Number Publication Date
AR042900A1 true AR042900A1 (es) 2005-07-06

Family

ID=32669255

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP040100138A AR042900A1 (es) 2003-01-28 2004-01-19 Productos n-aril-heteroaromaticos, composiciones que les contienen y su utilizacion

Country Status (9)

Country Link
AR (1) AR042900A1 (es)
CL (1) CL2004000045A1 (es)
FR (1) FR2850379B1 (es)
GT (1) GT200300267A (es)
PA (1) PA8594301A1 (es)
PE (1) PE20040766A1 (es)
SV (1) SV2004001710A (es)
TW (1) TW200504026A (es)
UY (1) UY28173A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017310529B2 (en) * 2016-08-12 2021-08-19 Edwin J. Iwanowicz Protein kinase regulators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449350A (en) * 1968-06-24 1969-06-10 Ciba Geigy Corp Certain pyrazole-3-carboxylic acid hydrazide derivatives
US3778433A (en) * 1969-04-18 1973-12-11 Sumitomo Chemical Co Process for producing benzodiazepine derivatives
JPS61129129A (ja) * 1984-11-28 1986-06-17 Kureha Chem Ind Co Ltd 抗腫瘍剤
TW312694B (es) * 1994-09-26 1997-08-11 Daiichi Seiyaku Co
EA005934B1 (ru) * 2001-07-05 2005-08-25 Х. Лундбекк А/С Замещённые анилиновые пиперидины в качестве селективных антагонистов мсн

Also Published As

Publication number Publication date
SV2004001710A (es) 2004-03-19
FR2850379B1 (fr) 2006-11-17
GT200300267A (es) 2004-02-24
PE20040766A1 (es) 2004-12-14
PA8594301A1 (es) 2004-08-31
UY28173A1 (es) 2004-08-31
FR2850379A1 (fr) 2004-07-30
TW200504026A (en) 2005-02-01
CL2004000045A1 (es) 2005-01-07

Similar Documents

Publication Publication Date Title
CY1124284T1 (el) Ενωσεις σπειρο[3η-ινδολο-3,2'-πυρρολιδιν]-2(1η)-ονης και παραγωγα ως αναστολεις mdm2-p53
AR044586A1 (es) Productos aril - heteroaromaticos, composiciones que los contienen y su utilizacion
AR079541A1 (es) Compuestos sustituidos de n-(1h-indazol-4-il) imidazo (1,2-a) piridin-3-carboxamida como inhibidores de cfms
PE20161443A1 (es) Compuestos
AR094494A1 (es) Pirrolopirimidinas sustituidas, sus composiciones, y sus métodos de tratamiento
AR108068A1 (es) Compuestos bicíclicos
AR076435A1 (es) Compuestos de indazoles sustituidos, composiciones farmaceuticas que los contienen y procesos de obtencion de los mismos
PE20110062A1 (es) N-(3-(3,5-dimetoxifenetil)-1h-pirazol-5-il)-4-(3,4-dimetilpiperazin-1-il)benzamida y sales del mismo
PE20141405A1 (es) Nuevos derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR045083A1 (es) Productos aril-heteroaromaticos, composiciones que los contienen y utilizacion como medicamento
PH12019500712B1 (en) BENZO[b]THIOPHENE COMPOUNDS AS STING AGONISTS
ME02373B (me) Biciklična heterociklična jedinjenja kao inhibitori protein tirozin kinaze
PE20190971A1 (es) Compuestos quimicos
PE20141974A1 (es) Compuestos de heterociclilo
MY192521A (en) Bicyclic-fused heteroaryl or aryl compounds and their use as irak4 inhibitors
NZ610312A (en) 6-amino-2-phenylamino-1h-benzimidazole-5-carboxamide- derivatives and their use as microsomal prostaglandin e2 synthase-1 inhibitors
GEAP201814248A (en) 2-amino-3, 5, 5-trifluoro-3, 4, 5, 6-tetrahydropyridines as bace1 inhibitors for treatment of alzheimer's disease
SG10201806565SA (en) Heterocyclic carboxylic acids as activators of soluble guanylate cyclase
PE20061305A1 (es) Compuestos derivados de fenilacetamidas como inhibidores de proteincinasas
UA102679C2 (ru) Бициклические производные азабициклических карбоксамидов, их получение и их применение в терапии
HRP20120762T1 (hr) Tetrasupstituirani piridazini kao inhibitori hedgehog puta
MD20160105A2 (ro) 2-Amino-6-metil-4,4a,5,6-tetrahidropirano[3,4-d][1,3]tiazin-8a(8H)-il-1,3-tiazol-4-il amide
CY1114318T1 (el) Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες
PE20141352A1 (es) Fenil-3-aza-biciclo[3,1,0]hex-3-il-metanonas y su uso como medicamento
MY169179A (en) Novel piperidine compound or salt thereof

Legal Events

Date Code Title Description
FB Suspension of granting procedure